key: cord-0900070-upgmzeul authors: Archambault, A.-S.; Zaid, Y.; Rakotoarivelo, V.; Dore, E.; Dubuc, I.; Martin, C.; Amar, Y.; Cheikh, A.; Fares, H.; El Hassani, A.; Tijani, Y.; Laviolette, M.; Boilard, E.; Flamand, L.; Flamand, N. title: Lipid storm within the lungs of severe COVID-19 patients: Extensive levels of cyclooxygenase and lipoxygenase-derived inflammatory metabolites. date: 2020-12-07 journal: nan DOI: 10.1101/2020.12.04.20242115 sha: 50b6707792eec87c217d65276210ba46e30ce5fc doc_id: 900070 cord_uid: upgmzeul BACKGROUND. Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for Coronavirus disease 2019 (COVID-19). While SARS-CoV-2 infections are often benign, there are also severe COVID-19 cases, characterized by severe bilobar pneumonia that can decompensate to an acute respiratory distress syndrome, notably characterized by increased inflammation and a cytokine storm. While there is no cure against severe COVID-19 cases, some treatments significantly decrease the severity of the disease, notably aspirin and dexamethasone, which both directly or indirectly target the biosynthesis (and effects) of numerous bioactive lipids. OBJECTIVE. Our working hypothesis was that severe COVID-19 cases necessitating mechanical ventilation were characterized by increased bioactive lipid levels modulating lung inflammation. We thus quantitated several lung bioactive lipids using liquid chromatography combined to tandem mass spectrometry. RESULTS. We performed an exhaustive assessment of the lipid content of bronchoalveolar lavages from 25 healthy controls and 33 COVID-19 patients necessitating mechanical ventilation. Severe COVID-19 patients were characterized by increased fatty acid levels as well as an accompanying inflammatory lipid storm. As such, most quantified bioactive lipids were heavily increased. There was a predominance of cyclooxygenase metabolites, notably TXB2 >> PGE2 {approx} 12-HHTrE > PGD2. Leukotrienes were also increased, notably LTB4, 20-COOH-LTB4, LTE4, and eoxin E4. 15-lipoxygenase metabolites derived from linoleic, arachidonic, eicosapentaenoic and docosahexaenoic acids were also increased. Finally yet importantly, specialized pro-resolving mediators, notably lipoxin A4 and the D-series resolvins, were also found at important levels, underscoring that the lipid storm occurring in severe SARS-CoV-2 infections involves pro- and anti-inflammatory lipids. CONCLUSIONS. Our data unmask the important lipid storm occurring in the lungs of patients afflicted with severe COVID-19. We discuss which clinically available drugs could be helpful at modulating the lipidome we observed in the hope of minimizing the deleterious effects of pro-inflammatory lipids and enhancing the effects of anti-inflammatory and/or pro-resolving lipids. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the Severe Acute Respiratory 81 Syndrome coronavirus 2 (SARS-CoV-2) (1). The clinical manifestations of the disease are often mild 82 but severe cases can lead to bilobar pneumonia with hyperactivation of the inflammatory cascade and 83 progression to acute respiratory distress syndrome (ARDS), necessitating mechanical ventilation (2, 3). 84 SARS-CoV-2 spreads predominantly from respiratory droplets of infected individuals to mucosal 85 epithelial cells in the upper airways and oral cavity (4). It infects cells via its homotrimeric spike protein 86 binding to host-cell expressing angiotensin-converting enzyme-2 (ACE2) receptor in a protease-87 dependent manner (5). 88 89 Autopsies from severe COVID-19 patients unmasked a heterogeneous disease that can be characterized 90 by diffuse alveolar damage, endothelial damage, thrombosis of small and medium vessels, pulmonary 91 2 hrs following intubation and as follows: a total of 100 ml of sterile 0.9% saline (2 boli of 50 ml) was 147 injected in a sub-segmental bronchi of the right middle lobe. The obtained lavages were pooled and 148 centrifuged (320 × g, 15 minutes) to pellet cells. Supernatants were next concentrated as for the BALs of 149 healthy donors using a stream of nitrogen and immediately frozen (-80º Celsius) until further processing. 150 All of the evaporated samples were processed for LC-MS/MS analysis as described below. 151 152 LC-MS/MS analyses. Samples (500 µl) were denatured by adding 500 µl of LC-MS grade MeOH 153 containing the internal standards then warmed at 60º Celsius for 30 minutes to inactivate (or not) SARS-154 CoV-2. Samples were then denatured overnight (-20º Celsius). The morning after, samples were warmed 155 to room temperature and centrifuged at 10,000 × g to remove the denaturated proteins. The obtained 156 supernatants were diluted with water containing 0.01% acetic acid to obtain a MeOH concentration of 157 10%, then acidified to pH 3 with acetic acid. Lipids were extracted by solid phase extraction (SPE) using 158 Strata-X cartridges (Polymeric Reversed Phase, 60 mg/1 ml, Phenomenex, Torrance, CA, USA) as 159 described before (11). In brief, columns were preconditioned with 2 ml MeOH containing 0.01% acetic 160 acid followed by 2 ml LC-MS grade H2O containing 0.01% acetic acid. After sample loading, the 161 columns were washed with 2 ml LC-MS grade H2O containing 0.01% acetic acid. Lipids were then eluted 162 from the cartridges with 1 ml MeOH containing 0.01% acetic acid. Eluates were dried under a stream of 163 nitrogen and reconstituted with 25 µl of solvent A (H2O + 1 mM NH4 + 0.05% acetic acid) and 25 µl of 164 solvent B (MeCN/H2O, 95/5, v/v + 1 mM NH4 + 0.05% acetic acid). A volume of 40 µl of the resulting 165 mixture was injected onto a RP-HPLC column (Kinetex C8, 150 × 2.1 mm, 2.6 µm, Phenomenex). 166 Samples were eluted at a flow rate of 400 µl/min with a linear gradient of 10% solvent B that increased 167 to 35% in 2 min, up to 75% in 10 min, from 75% to 95% in 0.1 min, and held at 98% for 5 min before 168 re-equilibration to 10% solvent B for 2 min. The HPLC system was directly interfaced into the 169 electrospray source of a Shimadzu 8050 triple quadrupole mass spectrometer and mass spectrometric 170 analyses were performed in the positive (+) or the negative (−) ion mode using multiple reaction 171 monitoring for the specific mass transitions of each lipid ( Table 2) . Quantification of each compound 172 was done using internal standards and calibration curves that were extracted by solid-phase extraction as 173 described above. 174 175 Statistical analyses were done using the GraphPad Prism 9 software. P values < 0.05 were considered 177 significant. 178 179 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint While the circulating (plasmatic) cytokines' profile observed in severe COVID-19 patients is relatively 181 well-defined (8, 12-14), a much more limited number of studies characterizing the cytokine storm in the 182 lungs of severe COVID-19 patients were available (13, 15, 16) . In fact, to the best of our knowledge, no 183 study simultaneously quantitated numerous soluble mediators in BAL fluids. We thus performed their 184 lipidomic analysis in order to define whether an inflammatory lipid storm was present in the lungs of 185 severe COVID-19 patients. Samples were compared to those obtained from healthy subjects. As a 186 starting point, we investigated eicosanoids derived from the cyclooxygenase (COX) pathway. Our 187 working hypothesis was that some COX metabolites would be increased, considering that IL-1β levels 188 are elevated in the BALs of some COVID-19 patients (16) and that IL-1β is a potent inducer of 189 cyclooxygenase (COX)-2 expression (17-19). The only COX metabolites that were detected in the BALs 190 of healthy subjects were PGD2 (16 donors out of 25) and 12-HHTrE (2 donors out of 25). In contrast, 191 BALs from severe COVID-19 patients had a significant increase of all COX metabolites investigated 192 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint expected, there was a strong correlation between the levels of LTB4 and those of 20-COOH-LTB4 (figure 213 2B). Importantly, the ratio between the sum of 20-OH-and 20-COOH-LTB4 to LTB4 ((20-OH-+ 20-214 COOH-LTB4)/LTB4) was 2.843 +/-0.532 (mean +/-SEM), indicating an increased omega oxidation of 215 LTB4. The levels of LTB4 strongly correlated with those of TXB2 (figure 2C). The cysteinyl-leukotrienes 216 LTE4 and EXE4 were also found in most severe COVID-19 patients ( figure 2D) . Surprisingly, the levels 217 of EXE4 trended to be higher than those of LTE4. Furthermore, there was a trend toward a negative 218 correlation between LTE4 and EXE4 levels although it did not reach statistical significance ( figure 2E) . 219 This suggests that some COVID-19 patients are more prone to biosynthesize the 15-lipoxygnease-220 derived EXC4 while others are more prone to biosynthesize the 5-lipoxygenase-derived LTC4. Of note, 221 LTB4 levels correlated with those of EXE4 but not with those of LTE4 ( figure 2F,G) . Again, a limited 222 number of correlations between the different leukotrienes and the clinical parameters from Table 1 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ibuprofen are recognized inhibitor of cyclooxygenase activity. Early at the beginning of the pandemic, it 311 was postulated that NSAIDs could worsen the severity of COVID-19 (38). However, a Danish study 312 indicated that ibuprofen was not linked to severe adverse outcome (39). Furthermore, aspirin was recently 313 shown to significantly diminish ICU admissions and the need of mechanical ventilation in an 314 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. Conceptually, this might diminish the effectiveness of LTB4 at promoting its host-defense related 332 functions, as we recently published (46). Interestingly, there was a trend toward an inverse correlation 333 between LTE4 and EXE4, indicating that these cysteinyl-LTs are likely coming from different cellular 334 sources. This was supported by the differential and significant correlations between the different lipids 335 we observed, LTE4 and EXE4 differentially correlating with distinct lipids (figure 6). To that end, EXE4 336 levels in the BALs positively and significantly correlated with blood eosinophils counts. While there was 337 a strong trend between EXE4 and BAL eosinophils counts the latter correlation had a p value of 0.0536. 338 Altogether, this suggests that the presence and/or biosynthesis of eoxins is, in part, linked to eosinophils. 339 A therapeutic approach to target LTs from the 5-lipoxygenase pathway could be the use of Zileuton, 340 which is commercially available for the management of asthma and has a good safety profile (47). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. was somewhat surprising as they are generally thought to appear during the resolution of inflammation, 366 after the biosynthesis of prostaglandins and leukotrienes has occurred and following a class-switch from 367 pro-inflammatory to pro-resolving lipids (62). However, our data indicate that prostaglandins, 368 leukotrienes and SPMs can certainly co-exist and participate in the inflammatory cascade during the 369 acute phase of inflammation/infection in which resolution has not been fully engaged. Moreover, given 370 their strong documented anti-inflammatory effects and their host-defense boosting functions, they could 371 be viewed as potential mediators to enhance to limit the infection. To that end, it was recently proposed 372 that dexamethasone could participate in the upregulation of SPM biosynthesis and effects in moderate to 373 severe COVID-19 patients, although this needs to be confirmed (63). While omega-3 fatty acids, notably 374 purified preparation enriched in EPA and DHA are commercially available as dietary supplements, we 375 did not see a correlation between SPMs and the levels of EPA or DHA, indicating that SPMs levels are 376 likely more dependent on biosynthetic enzymes other than phospholipases such as lipoxygenases than 377 EPA or DHA availability. As of today, no resolution pharmacology treatment has been approved by 378 governmental health agencies yet. However, some putative E-and D-series resolvin precursors, notably 379 18-HEPE and 17-HDHA, are available as dietary supplements. 380 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. 19 patients did not include the number of alveolar macrophages and it is thus impossible to determine a 407 clear differential count of leukocytes in those samples. Furthermore, the eosinophil counts were 408 somewhat limited by the apparatus as it could estimate the counts to +/-10 5 /ml cells, which likely has an 409 impact on the different correlations involving eosinophils, notably with EXE4; 4) We could not compare 410 the levels of lipids in the BALs of severe COVID-19 patients to those found in the blood. This appears 411 important given the limited number of correlations found between BAL lipids and other circulating 412 markers such as CRP and D-dimers. To that end, a recent study indicated differences in some of the 413 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint herein investigated bioactive lipids in the circulation (68). It will thus be important to pursue our 414 investigations and determine whether there is a transposition of the BAL lipidome to the circulation. 415 In conclusion, our data unmask that in addition to the recognized cytokine storm previously documented, 417 lung fluids of SARS-CoV-2-infected patients indicate that a lipid storm also occurs. As highlighted 418 above, the rich library of governmental health agencies-approved lipid modulators might provide 419 beneficial and usually low-cost add-ons to the current therapeutic arsenal utilized to diminish the severity 420 of COVID-19 and possibly additional coronavirus-mediated infections. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint BALs were obtained and processed as described in Methods. Lipids then were extracted and quantitated 697 by LC-MS/MS. Results are from the BALs from 25 healthy subjects and 33 severe COVID19 patients. 698 P values were obtained by performing a Mann-Whitney test: **** p < 0.0001. 699 700 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. Whitney test: * p < 0.05; ** p < 0.01; **** p < 0.0001. B-G) Correlation tests were performed with 716 severe COVID-19 patients by using the non-parametric Spearman's rank. P<0.05 was the threshold of 717 significance. The linear regression is represented with a solid line and the best-fit lines of 95% confidence 718 are represented with dotted lines. 719 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint shown using shades of green and negative correlation are shown using shades of red. 727 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.04.20242115 doi: medRxiv preprint Transcriptomic characteristics of 478 bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients Single-cell landscape of bronchoalveolar immune cells in patients with 482 COVID-19 The 484 heterologous expression and characterization of human prostaglandin G/H synthase-2 (COX-2) Dexamethasone suppression of IL-1b-induced 487 cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells Vane 490 JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: 491 regulation by dexamethasone Increased concentrations of 493 leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult 497 respiratory distress syndrome A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-499 19 by Targeting Leukotrienes Eoxins are proinflammatory arachidonic acid metabolites 502 produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells Inflammation resolution: a dual-pronged approach to averting cytokine storms 506 in COVID-19? Platelet gene expression 509 and function in patients with COVID-19 Platelet activation and platelet-monocyte 512 aggregate formation trigger tissue factor expression in patients with severe COVID-19 an 515 orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to 516 mast cell-derived factor(s) Prostaglandin D2 is a potent 518 chemoattractant for human eosinophils that acts via a novel DP receptor Prostaglandin D2 selectively induces chemotaxis in T helper 522 type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 Metabolomic profiling of regulatory 574 lipid mediators in sputum from adult cystic fibrosis patients Generation and 577 metabolism of leukotrienes in granulocytes of patients with cystic fibrosis Arachidonic acid metabolites from 580 polymorphonuclear leukocytes of healthy donors, severely burned patients and children with 581 cystic fibrosis--routine monitoring by high-performance liquid chromatography Metabolism of leukotriene B4 by 584 polymorphonuclear granulocytes of severely burned patients 20-Hydroxy-and 20-588 carboxy-leukotriene (LT) B4 downregulate LTB4-mediated responses of human neutrophils and 589 eosinophils Global Initiative for the Diagnosis, Management, and Prevention of Chronic 593 Obstructive Lung Disease: The 2020 GOLD Science Committee Report on COVID-19 & 594 COPD Influence of isoproterenol 599 and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human 600 neutrophil Phosphodiesterase 4-dependent regulation of cyclic AMP levels and 602 leukotriene B4 biosynthesis in human polymorphonuclear leukocytes Adenosine, a potent natural suppressor of arachidonic 606 acid release and leukotriene biosynthesis in human neutrophils Histamine-induced inhibition of 609 leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP The Endocannabinoid Metabolite Prostaglandin E2 (PGE2)-Glycerol Inhibits 613 Human Neutrophil Functions: Involvement of Its Hydrolysis into PGE2 and EP Receptors Effects of pyrrophenone, an 616 inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human 617 neutrophils Purified group X secretory phospholipase A2 induced prominent 620 release of arachidonic acid from human myeloid leukemia cells Cellular arachidonate-releasing function of novel classes of 624 secretory phospholipase A2s (groups III and XII) Function of 626 secreted phospholipase A2 group-X in asthma and allergic disease Regulation and function of 630 epithelial secreted phospholipase A2 group X in asthma Generation of lyso-phospholipids from surfactant in acute 634 lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein 635 A-phospholipase A2 protein interaction Transgenic expression of group V, but not group X, 638 secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction Proresolving lipid mediators and mechanisms in the 641 resolution of acute inflammation Dexamethasone, pro-resolving lipid mediators and 643 resolution of inflammation in COVID-19 Regulation of inflammation by cannabinoids, 645 the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their 646 metabolites The CB2 receptor and its role as a regulator of 648 inflammation New approaches and challenges to targeting the endocannabinoid system Age-related increases in PGD2 expression impair respiratory 652 DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice Severe SARS-CoV-2 infection in humans is defined by a shift in the 656 serum lipidome resulting in dysregulation of eicosanoid immune mediators Figure 2. Comparison of leukotriene and eoxin levels in the BAL fluids of healthy subjects and 686 severe COVID-19 patients. A,D) BALs were obtained and processed as described in methods Correlation tests were performed with severe COVID-690 19 patients by using the non-parametric Spearman's rank. P<0.05 was the threshold of significance. The 691 linear regression is represented with a solid line and the best Comparison of 12-and 15-lipoxygenase-derived oxylipins and diHETEs levels in the 702 BALs of healthy subjects and severe COVID-19 patients. A-D) BALs were obtained and processed 703 as described in Methods. Lipids then were extracted and quantitated by LC-MS/MS. Results are from the 704 BALs from 25 healthy subjects and 33 Severe COVID-19 patients No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted